A Phase 1 Open Label, Randomized Clinical Trial Assessing Safety of MF101 for Hot Flushes and Menopausal Symptoms in Postmenopausal Women.
Latest Information Update: 22 Nov 2011
At a glance
- Drugs MF 101 (Primary)
- Indications Hot flashes
- Focus Adverse reactions
- 30 Aug 2011 Patient numbers are 35 (actual), as reported in the Bionova media release.
- 30 Aug 2011 Status changed from active, no longer recruiting to completed, as reported in a Bionovo media release.
- 26 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.